Showing 2211-2220 of 3329 results for "".
- FDA Issues Safety Alert for SCC and Various Lymphomas in Scar Tissue around Breast Implantshttps://modernaesthetics.com/news/fda-issues-safety-alert-for-scc-and-various-lymphomas-in-scar-tissue-around-breast-implants/2473297/The U.S. Food and Drug Administration (FDA) is informing patients and providers about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast implants. “After an initial extensive review, we currently believe that th
- CARE Curriculum Launched by DREAM Initiative from Allergan Aesthetics, SkinBetter Sciencehttps://modernaesthetics.com/news/care-curriculum-launched-by-dream-initiative-from-allergan-aesthetics-skinbetter-science/2473296/The DREAM Initiative®, developed by Allergan Aesthetics and skinbetter science®, has supported the development of a racial equity curriculum for dermatology residency programs. The Curriculum f
- FDA Approves Daxxify from Revancehttps://modernaesthetics.com/news/fda-approves-daxxify-from-revance/2473295/Daxxify™ (DaxibotulinumtoxinA-lanm) from Revance is FDA approved for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum
- Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERMhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-100-million-syringes-of-juvederm/2473294/Drumroll, please…Allergan Aesthetics, an AbbVie company, has produced and shipped 100 million syringes of JUVÉDERM products globally. Since its launch in 2000, the JUVÉDERM Collection of Fillers has grown to where its products are now available in mo
- FDA Grants 510(k)Clearance to LASEROPTEK's HELIOS IV-785 for Aesthetic and Medical Dermatology Usehttps://modernaesthetics.com/news/fda-grants-510kclearance-to-laseropteks-helios-iv-785-for-aesthetic-and-medical-dermatology-use/2473291/The U.S. Food and Drug Administration has granted 510(k) clearance to LASEROPTEK Co., Ltd.’s HELIOS IV-785 laser system for aesthetic and medical dermatology applications. HELIOS IV-785's novel and synergistic combination of 785nm picosecond photoacoustic effect and 1064 &
- FDA Approves Avéli for Long-Term Reduction of Cellulite In the Buttocks and Thighshttps://modernaesthetics.com/news/fda-approves-reveli-for-long-term-reduction-of-cellulite-in-the-buttocks-and-thighs/2473290/Revelle Aesthetics, Inc. scored an extended FDA clearance for Avéli. Avéli is now indicated for long-term reduction in the appearance of cellulite in the buttocks and thigh areas of adult females, demonstrating benefits through one year. "For far too l
- Allergan Aesthetics Announces Double Allē Points Promotion for Juvederm Usershttps://modernaesthetics.com/news/allergan-aesthetics-announces-double-alle-points-promotion-for-juvederm-users/2473281/Consumers can earn double points in Allē, Allergan Aesthetics' loyalty rewards program, when treated with two or three syringes from the JUVÉDERM Collection of Fillers during the same visit. Allē points can be redeemed for future Allē-eligible treatments or products.&nb
- New from Senté: Cysteamine HSA Pigment & Tone Correctorhttps://modernaesthetics.com/news/new-from-sente-cysteamine-hsa-pigment-tone-corrector/2473279/Cysteamine HSA Pigment & Tone Corrector from Senté has launched to safely and effectively target pigmentation in all skin tones. The hydroquinone-free formula is safe for long-term use and formulated for all skin types, including dry or sensitive skin. Cystea
- Alma Rolls Out Alma Hybrid and Alma TED Systems in Canadahttps://modernaesthetics.com/news/alma-rolls-out-alma-hybrid-and-alma-ted-systems-in-canada/2473278/Alma Hybrid and Alma TED systems are now commercially available in Canada, the company reports. Alma Hybrid, the first laser platform to include an ablative 10,600 nm (CO2) laser and a non-ablative 1570 nm laser for skin resurfacing that offers a comprehensive solution to utilize each b
- Aesthetics Biomedical Inc. Scores Third U.S. Patent for SoME Skincarehttps://modernaesthetics.com/news/aesthetics-biomedical-inc-scores-third-us-patent-for-some-skincare/2473277/Aesthetics Biomedical Inc. scored its third U.S. patent for “biological preserving composition and methods of use” for its SoME skincare product line. The patent covers topical compositions for combining biologics with skincare preserving the exclusivity of SoME Skincar